55065-94-6

Basic information

• Product Name: Acetamide, N-(4-bromo-3-hydroxyphenyl)-
• CAS NO: 55065-94-6
• Molecular Formula: C8H8BrNO2
• Molecular Weight: 230.061
• Mol File: 55065-94-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Acetamide, N-(4-bromo-3-hydroxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-(4-bromo-3-hydroxyphenyl)-(55065-94-6)
• EPA Substance Registry System: Acetamide, N-(4-bromo-3-hydroxyphenyl)-(55065-94-6)

Safety Data

• Hazardous Substances Data: 55065-94-6(Hazardous Substances Data)

Upstream product

• 55120-56-4 4-bromo-3-hydroxy-aniline 
• 75-36-5 acetyl chloride 
• 121-88-0 5-Nitro-2-aminophenol 
• 860209-11-6 3-amino-2-bromo-5-nitro-phenol 
• 116296-08-3 acetic acid-(3-hydroxy-5-nitro-anilide) 
• 586-11-8 3,5-dinitrophenol 
• 618-64-4 3-Amino-5-nitro-phenol 
• 7726-95-6 bromine 
• 64-19-7 acetic acid 
• 621-42-1 meta-hydroxyacetanilide 
• 52427-05-1 2-bromo-5-nitrophenol 

Downstream Products

• 55120-56-4 4-bromo-3-hydroxy-aniline 

Relevant articles and documents

THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES

A therapeutic agent for treating at least one disease selected from the group consisting of inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases, comprising: at least one selected from the group consisting of a compound represented by the following general formula (1) and pharmacologically acceptable salts thereof as an active ingredient. [In the formula (1), R1 and R2 may be the same or different and each represents a hydrogen atom, a halogen atom, a hydroxyl group, a carboxy group, a cyano group, an optionally substituted C1-6 alkyl group et al.; R3 represents a hydrogen atom; R4 represents an optionally substituted 4- to 10-membered monocyclic heterocyclic group containing 1 to 4 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom; X represents a group represented by the following formula: -CH2-, - CH2-CH2-, -CH2-CH2-CH2-, or -CH2-O-CH2-; and Z represents a hydrogen atom or a hydroxyl group.]

NOVEL COMPOUND AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF

A compound represented by the general formula (1) below or a pharmacologically acceptable salt thereof: [In the formula (1), R1 and R2 may be the same or different and each represents a hydrogen atom, a halogen atom, a hydroxyl group, a carboxy group, a cyano group, an optionally substituted C1-6 alkyl group et al.; R3 represents a hydrogen atom; R4 represents an optionally substituted 4- to 10-membered monocyclic heterocyclic group containing 1 to 4 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom; X represents a group represented by the following formula: —CH2—, —CH2—CH2—, —CH2—CH2—CH2—, or —CH2—O—CH2—; and Z represents a hydrogen atom or a hydroxyl group.]